Showing results (181-190 of 197) with videos related to

Sort By:
Pageof 20
Proceedings of the National Academy of Sciences of the United States of America|August 21, 2015
Nonmuscle myosin heavy chain IIA mediates Epstein-Barr virus infection of nasopharyngeal epithelial cellsDan Xiong, Yong Du, Hong-Bo Wang, et al.
Ebiomedicine|June 25, 2026
A multi-centre, phase 1a/1b dose escalation and expansion study of the HER2-directed antibody-drug conjugate T-Bren (BL-M07D1) in advanced breast cancer and other solid tumoursHerui Yao, Ruihua Zhao, Xiuping Lai, et al.
JAMA Network Open|December 8, 2020
Development and Validation of a Preoperative Magnetic Resonance Imaging Radiomics-Based Signature to Predict Axillary Lymph Node Metastasis and Disease-Free Survival in Patients With Early-Stage Breast CancerYunfang Yu, Yujie Tan, Chuanmiao Xie, et al.
Oncotarget|April 28, 2015
Mitochondrial fission determines cisplatin sensitivity in tongue squamous cell carcinoma through the BRCA1-miR-593-5p-MFF axisSong Fan, Bodu Liu, Lijuan Sun, et al.
The Journal of Clinical Investigation|March 4, 2020
PIK3Cδ expression by fibroblasts promotes triple-negative breast cancer progressionTeresa Gagliano, Kalpit Shah, Sofia Gargani, et al.
Nature Cancer|February 5, 2022
The IRENA lncRNA converts chemotherapy-polarized tumor-suppressing macrophages to tumor-promoting phenotypes in breast cancerJiang Liu, Liyan Lao, Jianing Chen, et al.
Cell Research|February 3, 2018
Tamoxifen enhances stemness and promotes metastasis of ERα36+ breast cancer by upregulating ALDH1A1 in cancer cellsQiang Wang, Jun Jiang, Guoguang Ying, et al.
Cancer Research|September 14, 2014
MicroRNA100 inhibits self-renewal of breast cancer stem-like cells and breast tumor developmentLu Deng, Li Shang, Shoumin Bai, et al.
Annals of Translational Medicine|November 26, 2015
National consensus in China on diagnosis and treatment of patients with advanced breast cancerBinghe Xu, Xichun Hu, Zefei Jiang, et al.
Science China. Life Sciences|May 17, 2022
A 10-miRNA risk score-based prediction model for pathological complete response to neoadjuvant chemotherapy in hormone receptor-positive breast cancerChang Gong, Ziliang Cheng, Yaping Yang, et al.
Pageof 20